Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/18/19
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 10/26/17
End: 03/25/21
Due: 03/25/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines | NCT03753074 | Young-Suk Lim | user2@example.com | None | 2019-02-18 | 2031-12-31 | 2032-12-31 | - | - | 2025-07-14 |
| Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. | NCT03241641 | Young-Suk Lim | user2@example.com | None | 2017-10-26 | 2021-03-25 | 2022-03-25 | - | - | 2025-07-14 |